| ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer (Journal of Translational Medicine) |
| 3 july 2020 21:50:10 |
| ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer (Journal of Translational Medicine) |
Immunotherapy with checkpoint inhibitors (CPI) targeting PD-1 or CTLA-4 has emerged as an important treatment modality for several cancer forms. In hormone receptor positive breast cancer (HR + BC), this thera... Tweet |
| 358 viewsCategory: Medicine |
| blog comments powered by Disqus |
| Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice. |
MyJournals.org - The latest issues of all your favorite science journals on one page